SUN-LB26 Radioligand Theranostics of Endocrine-Related Cancers; A New, Revolutionary Approach

por Harris, Alan G, O’Dorisio, Sue M
Publicado 2020

Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues

por Anthony, Lowell B., O'Dorisio, Thomas M.
Publicado 2021

Growing vascular endothelial cells express somatostatin subtype 2 receptors

por Watson, J C, Balster, D A, Gebhardt, B M, O'Dorisio, T M, O'Dorisio, M S, Espenan, G D, Drouant, G J, Woltering, E A
Publicado 2001

Addition of (131)I-MIBG to PRRT ((90)Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

por Bushnell, David L., Bodeker, Kellie L., O’Dorisio, Thomas M., Madsen, Mark T., Menda, Yusuf, Graves, Stephen, Zamba, Gideon K.D., O’Dorisio, M. Sue
Publicado 2021

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients

por Theiler, Deborah, Cattaneo, Marco, Dierickx, Lawrence O., Igaz, Peter, Grozinsky-Glasberg, Simona, Bournaud, Claire, O’Dorisio, Thomas, O’Dorisio, M. Sue, Wild, Damian, Christ, Emanuel, Nicolas, Guillaume P.
Publicado 2021

The current status of somatostatin receptors in malignant melanoma.

por Fletcher, W. S., Lum, S. S., Nance, R. W., Pommier, R. F., O'Dorisio, M. S.
Publicado 1997

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

por Bodei, L., Mueller-Brand, J., Baum, R. P., Pavel, M. E., Hörsch, D., O’Dorisio, M. S., O’Dorisio, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J., Zaknun, J. J.
Publicado 2013

Gastroenteropancreatic neuroendocrine tumors in children and young adults

por Khanna, Geetika, O’Dorisio, Sue M., Menda, Yusuf, Kirby, Patricia, Kao, Simon, Sato, Yutaka
Publicado 2007

Prospective Analysis of the Impact of (68)Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors

por Ghobrial, Silvia N., Menda, Yusuf, Zamba, Gideon K., Mott, Sarah L., Gaimari-Varner, Kristin, Dick, David, Dillon, Joseph, Howe, James R., Graham, Michael, Sunderland, John, Bellizzi, Andrew, O’Dorisio, Thomas M., O’Dorisio, M. Sue
Publicado 2020

MicroRNA-203 contributes to skin re-epithelialization

por Viticchiè, G, Lena, A M, Cianfarani, F, Odorisio, T, Annicchiarico-Petruzzelli, M, Melino, G, Candi, E
Publicado 2012

Innovative Cell and Platelet Rich Plasma Therapies for Diabetic Foot Ulcer Treatment: The Allogeneic Approach

por Mastrogiacomo, Maddalena, Nardini, Marta, Collina, Maria Chiara, Di Campli, Cristiana, Filaci, Gilberto, Cancedda, Ranieri, Odorisio, Teresa
Publicado 2022

Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

por Bushnell, David L, Madsen, Mark T, O’cdorisio, Thomas, Menda, Yusuf, Muzahir, Saima, Ryan, Randi, O’dorisio, M Sue
Publicado 2014

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

por Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuki, O’Dorisio, M Sue, Waschek, James A., Tan, Yossan-Var
Publicado 2016

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

por Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuqi, O’Dorisio, M. Sue, Waschek, James A., Tan, Yossan-Var
Publicado 2017

Management of Diarrhea in Patients With Carcinoid Syndrome

por Naraev, Boris G., Halland, Magnus, Halperin, Daniel M., Purvis, Amy J., O'Dorisio, Thomas M., Halfdanarson, Thorvardur R.
Publicado 2019

Vitiligo and Autoimmune Thyroid Disorders

por Baldini, Enke, Odorisio, Teresa, Sorrenti, Salvatore, Catania, Antonio, Tartaglia, Francesco, Carbotta, Giovanni, Pironi, Daniele, Rendina, Roberta, D’Armiento, Eleonora, Persechino, Severino, Ulisse, Salvatore
Publicado 2017

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma

por Jha, Abhishek, de Luna, Kristine, Balili, Charlene Ann, Millo, Corina, Paraiso, Cecilia Angela, Ling, Alexander, Gonzales, Melissa K., Viana, Bruna, Alrezk, Rami, Adams, Karen T., Tena, Isabel, Chen, Alice, Neuzil, Jiri, Raygada, Margarita, Kebebew, Electron, Taieb, David, O'Dorisio, M. Sue, O'Dorisio, Thomas, Civelek, Ali Cahid, Stratakis, Constantine A., Mercado-Asis, Leilani, Pacak, Karel
Publicado 2019

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting

por Wirzenius, Maria, Tammela, Tuomas, Uutela, Marko, He, Yulong, Odorisio, Teresa, Zambruno, Giovanna, Nagy, Janice A., Dvorak, Harold F., Ylä-Herttuala, Seppo, Shibuya, Masabumi, Alitalo, Kari
Publicado 2007

Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach

por Gelhorn, Heather L., Kulke, Matthew H., O’Dorisio, Thomas, Yang, Qi M., Jackson, Jessica, Jackson, Shanna, Boehm, Kristi A., Law, Linda, Kostelec, Jacqueline, Auguste, Priscilla, Lapuerta, Pablo
Publicado 2016

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy

por Tran, Catherine G., Borbon, Luis C., Mudd, Jacqueline L., Abusada, Ellen, AghaAmiri, Solmaz, Ghosh, Sukhen C., Vargas, Servando Hernandez, Li, Guiying, Beyer, Gabriella V., McDonough, Mary, Li, Rachel, Chan, Carlos H.F., Walsh, Susan A., Wadas, Thaddeus J., O’Dorisio, Thomas, O’Dorisio, M Sue, Govindan, Ramaswamy, Cliften, Paul F., Azhdarinia, Ali, Bellizzi, Andrew M., Fields, Ryan C., Howe, James R., Ear, Po Hien
Publicado 2022